Hanx Biopharma Launches AI Drug Development Collaboration With TwinEdge
() -- Hanx Biopharmaceuticals (Wuhan) (HKG:3378) has begun an artificial intelligence-driven drug development collaboration with Switzerland-based TwinEdge Bioscience, according to a Thursday Hong Kong bourse filing. The collaboration will use TwinEdge's artificial intelligence technology and digital twin models to sup